Rory Aufderheide, MD
Student in an Organized Health Care Education/Training Program in Tohatchi, New Mexico.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 331,274 in Student in an Organized Health Care Education/Training Program, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Rory Aufderheide, MD reported a CMS MIPS final score of 73.1/100 - below the 83.1 national average - and filed 1,064 Medicare Part D claims in 2023.
- 73.1/100
- MIPS score · -10 vs avg
- 1K
- Part D claims, 2023
- 63%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Rory Aufderheide, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
73 11th percentile higher than 11% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Rory Aufderheide, MD sits
This provider among student in an organized health care education/training program peers
Across the 12,645 student in an organized health care education/training program providers who report both Medicare Part D prescribing and a MIPS quality score, Rory Aufderheide, MD writes more Part D claims than 80% of them and scores higher on MIPS quality than 7% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one student in an organized health care education/training program peer from a representative sample of 60; the gold marker is Rory Aufderheide, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Rory Aufderheide, MD?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New Mexico
How Student in an Organized Health Care Education/Training Program compares to other specialties among New Mexico providers
Student in an Organized Health Care Education/Training Program ranks #4 among New Mexico's specialties (3.9% of in-state providers)
Each bar is a specialty's share of the New Mexico provider total, by primary NUCC taxonomy. The highlighted bar is Student in an Organized Health Care Education/Training Program; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Rory Aufderheide, MD's 2023 MIPS final score plotted against the Student in an Organized Health Care Education/Training Program national average
- MIPS Final Score
- 73.1/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Student in an Organized Health Care Education/Training Program) - 73.1/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Student in an Organized Health Care Education/Training Program US NPIs
73.1/100 MIPS final score - 10.0 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Student in an Organized Health Care Education/Training Program. Quality dim: 69.6. Cost dim: 49.4.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Rory Aufderheide, MD appears in the CMS NPPES registry as a Student in an Organized Health Care Education/Training Program provider holding MD credentials at 007 CHOOSGAI DRIVE, Tohatchi, NM, 87325, with a listed phone of (505) 733-8100. NPI 1912402819 was issued on 03/24/2018.
Medicare Part D records for calendar year 2023 show 1,064 prescription claims written by this provider, covering 125 Medicare beneficiaries and totaling roughly $405K in drug spend, split 34% brand-name and 63% generic by claim count, with an opioid prescribing rate of 1.0%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 73.1/100 for the 2023 performance year (Quality 69.6, Cost 49.4), compared with the national average of 83.1.
Student in an Organized Health Care Education/Training Program is a high-volume specialty nationwide, with 331,274 enrolled providers across 55 states and an average of 459 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1912402819 |
|---|---|
| Specialty | Student in an Organized Health Care Education/Training Program |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 03/24/2018 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Rory Aufderheide, MD's current license status, disciplinary history, and board certifications with the New Mexico Medical Board in New Mexico before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1912402819 is the unique 10-digit identifier CMS uses to link Aufderheide across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Rory Aufderheide, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Above average
34% brand-name claims vs 63% generic, on 1,064 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,137
- Total Day Supply
- 61,197
- Brand vs Generic
- 34% brand / 63% generic
- Brand Drug Cost
- $376K
- Generic Drug Cost
- $28K
- Opioid Claims
- 11 (1.0% rate)
- Antibiotic Claims
- 29
Patient Demographics
- Average Patient Age
- 71.1 years
- Avg HCC Risk Score
- 1.46
- Gender Split
- 60% female / 40% male
- Age Distribution
- <65: 29, 65-74: 46, 75-84: 32, 85+: 18
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Rory Aufderheide, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Lisinopril
Lisinopril
98 claims
- Ozempic
Ozempic
92 claims
- Jardiance
Jardiance
61 claims
- Diclofenac Sodium
Diclofenac Sodium
56 claims
- Amlodipine Besylate
Amlodipine Besylate
55 claims
- Metformin Hcl Er 37
Metformin Hcl Er
37 claims
- Atorvastatin Calcium 32
Atorvastatin Calcium
32 claims
- Metformin Hcl 30
Metformin Hcl
30 claims
| Drug | Claims |
|---|---|
| Lisinopril | 98 |
| Ozempic Semaglutide | 92 |
| Jardiance Empagliflozin | 61 |
| Diclofenac Sodium | 56 |
| Amlodipine Besylate | 55 |
| Metformin Hcl Er Metformin Hcl | 37 |
| Atorvastatin Calcium | 32 |
| Metformin Hcl | 30 |
| Simvastatin | 23 |
| Synthroid Levothyroxine Sodium | 23 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Student in an Organized Health Care Education/Training Program Overview
How Rory Aufderheide, MD fits within the Student in an Organized Health Care Education/Training Program landscape nationally.
Rory Aufderheide, MD's 1,064 claims are above the specialty average of 459.
Nearby Student in an Organized Health Care Education/Training Program Providers in New Mexico
Other clinicians with the same primary specialty enrolled in New Mexico, drawn from the same CMS NPPES roster as Aufderheide.
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New Mexico medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Student in an Organized Health Care Education/Training Program peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New Mexico
Frequently Asked Questions
What is Rory Aufderheide, MD's specialty? ▼
How much does Rory Aufderheide, MD prescribe under Medicare Part D? ▼
What is Rory Aufderheide, MD's Medicare quality score? ▼
Where is Rory Aufderheide, MD located? ▼
What is Rory Aufderheide, MD's NPI number? ▼
Does Rory Aufderheide, MD prescribe more brand-name or generic drugs? ▼
Does Rory Aufderheide, MD prescribe opioids? ▼
How many Student in an Organized Health Care Education/Training Program providers are there in the US? ▼
What drugs does Rory Aufderheide, MD prescribe most often? ▼
Does Rory Aufderheide, MD accept Medicare? ▼
How can I verify Rory Aufderheide, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor Editorial
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.